Back
Vertex Pharmaceuticals Vs. Expedia Group Industry Stock Comparison
Buy
71
VRTX
Vertex Pharmaceuticals
Last Price:
480.71
Seasonality Move:
10.1%
Buy
62
EXPE
Expedia Group
Last Price:
124.63
Seasonality Move:
3.72%
Buy
71
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $480.73. The Score for VRTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $124.61. The Score for EXPE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $480.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight buying pressure.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $124.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.36 | Buy |
| Relative Strength Index (14 RSI): | 70.74 | Buy |
| Chaikin Money Flow: | 22032 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (437.38 - 477.16) | Buy |
| Bollinger Bands (100): | (401.16 - 448.58) | Buy |
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 63.79 | Buy |
| Chaikin Money Flow: | 1409788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.39 - 120.53) | Buy |
| Bollinger Bands (100): | (118.56 - 142.94) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 481.49 | Sell |
| 20-day SMA: | 463.61 | Buy |
| 50-day SMA: | 429.15 | Buy |
| 200-day SMA: | 399.25 | Buy |
| 8-day EMA: | 477.35 | Buy |
| 20-day EMA: | 463.84 | Buy |
| 50-day EMA: | 441.97 | Buy |
| 200-day EMA: | 403.21 | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.19 | Buy |
| 20-day SMA: | 116.08 | Buy |
| 50-day SMA: | 122.11 | Buy |
| 200-day SMA: | 126.7 | Sell |
| 8-day EMA: | 121.84 | Buy |
| 20-day EMA: | 119.09 | Buy |
| 50-day EMA: | 121.93 | Buy |
| 200-day EMA: | 125.12 | Sell |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.60 per share, an increase this year of $2.00 per share, and an increase next year of $1.06 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.48 per share, a decrease next quarter of $2.64 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Vertex Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Expedia Group Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||